China’s stem cell diabetes breakthrough is not a headline from the future. It happened in June 2023, inside a hospital room in Tianjin, when a 25-year-old woman received an injection into her abdomen — an injection of cells that had, weeks earlier, been ordinary fat tissue taken from her own body. Seventy-five days later, she no longer needed insulin. She has not needed it since.
That sentence deserves to sit alone for a moment. Type 1 diabetes is an autoimmune condition in which the body destroys the pancreatic cells that produce insulin. It is not manageable like a software bug you patch and move on. It is a permanent structural failure — the immune system attacking itself — and for more than a century, the only way to live with it has been to become, in some functional sense, a machine: calculating carbohydrates, calibrating doses, monitoring blood glucose around the clock, every day, for life. For over 500 million people worldwide living with some form of diabetes, that is not a metaphor. It is Tuesday.
What Dr. Deng Hongkui and his team at Peking University did was not patch the bug. They rebuilt the organ.
…
Read the full article on Nspirement
Comments